Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 20/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8862022 | 1.00 | LTB4R (0.55) | LTB4R | |
| SCHEMBL7030035 | 0.99 | LTB4R (0.55) | LTB4R | |
| SCHEMBL7030031 | 0.99 | LTB4R (0.55) | LTB4R | |
| SCHEMBL8699763 | 0.88 | LTB4R (0.61) | LTB4R | |
| SCHEMBL8699765 | 0.88 | LTB4R (0.61) | LTB4R | |
| SCHEMBL9545830 | 0.87 | LTB4R (0.55) | LTB4R | |
| SCHEMBL7022628 | 0.87 | LTB4R (0.60) | LTB4R | |
| SCHEMBL9545831 | 0.87 | LTB4R (0.55) | LTB4R | |
| SCHEMBL7022636 | 0.87 | LTB4R (0.60) | LTB4R | |
| SCHEMBL7023822 | 0.86 | LTB4R (0.59) | LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5656636-A | TREATING PSORIASIS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-08-12 | — | — | US | disclosed |
| US-5633258-A | Pyridine compounds for treating leukotriene-related diseases | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5631262-A | Pyridine compounds for treating leukotriene-related diseases | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0639975-A1 | HETEROCYCLIC-SUBSTITUTED PYRIDINE COMPOUNDS AND USES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-03-01 | — | — | EP | disclosed |
| EP-0639975-A4 | HETEROCYCLIC-SUBSTITUTED PYRIDINE COMPOUNDS AND USES. | SMITHKLINE BEECHAM CORP (US) | 1994-10-24 | — | — | EP | disclosed |
| CN-1092409-A | The compound that is used for the treatment of leukotriene-related disease | SMITHKLINE BEECHAM CORP (US) | 1994-09-21 | — | — | CN | disclosed |
| EP-0604529-A1 | PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0593464-A1 | BENZOIC ACID DERIVATIVES and their use as LTB4 inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1994-04-27 | — | — | EP | disclosed |
| WO-1993011768-A1 | PYRIDYL COMPOUNDS FOR PSORIASIS TREATMENT | SMITHKLINE BEECHAM CORPORATION (US) | 1993-06-24 | — | — | WO | disclosed |
| CN-1073431-A | The compound that is used for the treatment of leukotriene-related disease | SMITHRLINE BEECHAM CORP (US) | 1993-06-23 | — | — | CN | disclosed |
| WO-1993010780-A1 | HETEROCYCLIC-SUBSTITUTED PYRIDINE COMPOUNDS AND USES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-06-10 | — | — | WO | disclosed |
| WO-1993006085-A1 | PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0593464-A4 | BENZOIC ACID DERIVATIVES. | SMITHKLINE BEECHAM CORP (US) | 1993-02-12 | — | — | EP | disclosed |
| WO-1991018601-A1 | BENZOIC ACID DERIVATIVES | SMITHKLINE BEECHAM CORPORATION (US) | 1991-12-12 | — | — | WO | disclosed |